Comment les médecins communiquent le pronostic génomique auprès des patients atteints de mélanome uvéal ? Résultats d’une étude qualitative
Open Access
- 6 November 2025
- journal article
- abstracts
- Published by Elsevier in Bulletin du Cancer
- Vol. 113 (2) , 165-174
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Management of metastatic uveal melanoma: French expert consensus guidelinesBulletin du Cancer, 2025
- Doit-on prendre en compte le stress informationnel de l’oncologue médical ?Bulletin du Cancer, 2024
- Cancer patient satisfaction with health care professional communication: An international EORTC studyPsycho-Oncology, 2021
- Discussing Prognosis with Empathy to Cancer PatientsCurrent Oncology Reports, 2021
- Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for cliniciansBreast Cancer Research and Treatment, 2019
- Communicating Uncertainty: a Narrative Review and Framework for Future ResearchJournal of General Internal Medicine, 2019
- International Validation of the American Joint Committee on Cancer’s 7th Edition Classification of Uveal MelanomaJAMA Ophthalmology, 2015
- Cross‐cultural differences in information disclosure evaluated through the EORTC questionnairesPsycho-Oncology, 2011
- Reactions to and Desire for Prognostic Testing in Choroidal Melanoma PatientsJournal of Genetic Counseling, 2009
- Survival in Patients With Uveal Melanoma in EuropeArchives of Ophthalmology (1950), 2008